| Literature DB >> 36177372 |
Abstract
Laparoscopic right colectomy is currently considered the standard treatment for right colon cancer. After excision of the right colon, minimally invasive options for ileocolonic anastomosis include extracorporeal anastomosis (EA) and intracorporeal anastomosis (IA). However, the choice of anastomotic technique remains debated. As the entire IA is performed in the abdominal cavity, it is known for its advantages of a faster intestinal recovery and small incision. However, IA is time-consuming and technically difficult, limiting its widespread use. Recently, the robotic approach has increased the adoption of intracorporeal anastomotic techniques owing to the benefits of endowrist-articulated instruments and staplers. Except for a small incision and faster bowel recovery, the outcomes of the two anastomoses methods are inconsistent. To date, there has been no clear conclusion regarding whether IA or EA should be used to treat right colon cancer. This review aimed to investigate the current evidence relating to intraoperative outcomes and short-term postoperative results between both anastomotic approaches.Entities:
Keywords: Anastomosis; Colectomy; Colonic neoplasms; Robotic surgical procedures; Surgical
Year: 2022 PMID: 36177372 PMCID: PMC9494010 DOI: 10.7602/jmis.2022.25.3.91
Source DB: PubMed Journal: J Minim Invasive Surg
Operative outcomes
| Study | Year | Conversion rate (%) | Incision length (cm) | Operative time (min) | Harvested lymph node | Blood loss | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
| |||||||||||
| IA | EA | IA | EA | IA | EA | IA | EA | IA | EA | ||||||
| Cleary et al. [ | 2022 | 0 | 5 | 4.9 ± 1.4 | 6.2 ± 3.6 | 156.9 ± 50.2 | 118.2 ± 43.5 | 23.3 ± 10.0 | 24.2 ± 9.5 | 1.3%[ | 0.8%[ | ||||
| Bollo et al. [ | 2020 | 0 | 0 | 6.7 (4–9.5) | 8.7 (5–13) | 149 (95–215) | 123 (60–240) | 19.7 ± 6.0 | 19.1 ± 7.1 | 8.8 ± 1.7[ | 17.1 ± 1.7[ | ||||
| Ferrer-Márquez et al. [ | 2021 | 1.2 | 2.98 | 6.38 ± 1.34 | 8.62 ± 3.13 | 100.1 ± 37.4 | 97.3 ± 28.0 | NR | NR | NR | NR | ||||
| Frigault et al. [ | 2022 | NR | NR | NR | NR | 160 ± 31 | 138 ± 42 | 32 ± 11 | 30 ± 13 | 41 ± 43 (mL) | 53 ± 69 (mL) | ||||
Values are presented as mean ± standard deviation or median (range) unless otherwise specified.
IA, intracorporeal anastomosis; EA, extracorporeal anastomosis; NR, not reported.
a)Intraoperative blood transfusion. b)Decrease in hemoglobin level (g/L).
Postoperative outcomes
| Study | Year | Bowel recovery (day) | Ileus (%) | Anastomotic leak (%) | SSI (%) | Reoperation (%) | Readmission (%) | Incisional hernia (%) | Hospital stay (day) | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
|
|
| |||||||||||||||||
| IA | EA | IA | EA | IA | EA | IA | EA | IA | EA | IA | EA | IA | EA | IA | EA | |||||||||
| Cleary et al. [ | 2022 | 1.5 ± 1.0[ | 1.8 ± 1.0[ | 4.5 | 1.6 | 0.6 | 0 | 1.3 | 0 | 0.6 | 0 | 2.6 | 0.8 | NR | NR | 4.2 ± 3.1 | 4.4 ± 1.5 | |||||||
| Bollo et al. [ | 2020 | 2.3 (1–7)[ | 3.3 (1–15)[ | 13 | 30 | 4 | 7 | 4 | 4 | 1 | 5 | 0 | 7 | NR | NR | 5.7 (2–19) | 6.6 (2–23) | |||||||
| Ferrer-Márquez et al. [ | 2021 | NR | NR | 22.0 | 19.2 | 4.9 | 7.7 | 3.7 | 16.7 | 7.3 | 12.8 | 6.09 | 3.85 | NR | NR | 11.1 ± 20.7 | 8.5 ± 5.75 | |||||||
| Frigault et al. [ | 2022 | 2 (2–3)[ | 2 (1–3)[ | 17.2 | 9.0 | 0 | 2.3 | 4.7 | 2.3 | 0 | 0.9 | 7.8 | 5.9 | 1.6 | 11.3 | 4 (3–6) | 4 (3–6) | |||||||
| Ishizaki et al. [ | 2021 | 2 (1–4)[ | 2 (1–4)[ | 5.9 | 8.0 | 0 | 0 | 7.8[ | 0[ | NR | NR | NR | NR | NR | NR | 10 (7–16) | 11 (7–23) | |||||||
Values are presented as mean ± standard deviation or median (range) unless otherwise specified.
SSI, surgical site infection; IA, intracorporeal anastomosis; EA, extracorporeal anastomosis; NR, not reported
a)Time to first flatus (day). b)Time to first passage of stool (day). c)Organ/space SSI.